# Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

> **NCT05799378** · PHASE3 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 330 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05799378
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-27
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-06-30
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- National Institutes of Health (NIH)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05799378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05799378, "Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05799378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*